- Home
- FEDU vs ENLV Comparison
FEDU vs ENLV Comparison
Compare FEDU & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEDU
- ENLV
- Stock Information
- Founded
- FEDU 2007
- ENLV 2005
- Country
- FEDU China
- ENLV Israel
- Employees
- FEDU N/A
- ENLV N/A
- Industry
- FEDU
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- FEDU
- ENLV Health Care
- Exchange
- FEDU NYSE
- ENLV Nasdaq
- Market Cap
- FEDU 21.6M
- ENLV 23.7M
- IPO Year
- FEDU 2017
- ENLV 1995
- Fundamental
- Price
- FEDU $13.94
- ENLV $1.45
- Analyst Decision
- FEDU
- ENLV Strong Buy
- Analyst Count
- FEDU 0
- ENLV 2
- Target Price
- FEDU N/A
- ENLV $10.00
- AVG Volume (30 Days)
- FEDU 2.7K
- ENLV 240.4K
- Earning Date
- FEDU 08-12-2025
- ENLV 08-29-2025
- Dividend Yield
- FEDU 17.15%
- ENLV N/A
- EPS Growth
- FEDU N/A
- ENLV N/A
- EPS
- FEDU 0.05
- ENLV N/A
- Revenue
- FEDU $34,475,202.00
- ENLV N/A
- Revenue This Year
- FEDU N/A
- ENLV N/A
- Revenue Next Year
- FEDU N/A
- ENLV N/A
- P/E Ratio
- FEDU $277.58
- ENLV N/A
- Revenue Growth
- FEDU 100.15
- ENLV N/A
- 52 Week Low
- FEDU $3.69
- ENLV $0.81
- 52 Week High
- FEDU $22.70
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- FEDU 53.99
- ENLV 65.99
- Support Level
- FEDU $14.59
- ENLV $1.12
- Resistance Level
- FEDU $15.96
- ENLV $1.66
- Average True Range (ATR)
- FEDU 0.31
- ENLV 0.10
- MACD
- FEDU -0.33
- ENLV 0.03
- Stochastic Oscillator
- FEDU 16.16
- ENLV 61.22
About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)
Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.